Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Annick Desjardins, Md

Clinical trials sponsored by Annick Desjardins, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New combo therapy aims to boost immune attack on brain cancer Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New combo therapy aims to boost immune attack on brain cancer

Disease control Ongoing

This phase 2 trial tests whether adding a dendritic cell vaccine and an immune-boosting drug (varlilumab) to standard chemotherapy can help people with newly diagnosed glioblastoma live longer. About 43 participants will receive the vaccine plus temozolomide, with some also getti…

Phase 2 • Sponsor: Annick Desjardins, MD • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC